BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38250762)

  • 1. Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer.
    Abd ELhafeez AS; Ghanem HM; Swellam M; Taha AM
    Cancer Biomark; 2024; 39(4):313-333. PubMed ID: 38250762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
    Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
    Front Oncol; 2020; 10():756. PubMed ID: 32509578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
    Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
    J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
    Chen S; Zhang Y; Ding X; Li W
    Front Genet; 2022; 13():838869. PubMed ID: 35386284
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision.
    El-Sheikh NM; Abulsoud AI; Fawzy A; Wasfey EF; Hamdy NM
    Pathol Res Pract; 2023 Jul; 247():154570. PubMed ID: 37244051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-146a-5p targets interleukin-1 receptor-associated kinase 1 to inhibit the growth, migration, and invasion of breast cancer cells.
    Long JP; Dong LF; Chen FF; Fan YF
    Oncol Lett; 2019 Feb; 17(2):1573-1580. PubMed ID: 30675215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
    Wang T; Zhang XD; Hua KQ
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and
    Tebbi L; Mansoori B; Safaei S; Hashemzadeh S; Shirmohamadi M; Hajiasgharzadeh K; Abdoli Shadbad M; Baradaran B
    Adv Pharm Bull; 2022 Aug; 12(4):842-849. PubMed ID: 36415628
    [No Abstract]   [Full Text] [Related]  

  • 11. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.
    Bi H; Shang Z; Jia C; Wu J; Cui B; Wang Q; Ou T
    Onco Targets Ther; 2020; 13():11277-11288. PubMed ID: 33177836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer
    Jiang B; Xia J; Zhou X
    Front Oncol; 2022; 12():712475. PubMed ID: 35372039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma microRNA signature associated with skeletal muscle wasting in post-menopausal osteoporotic women.
    Faraldi M; Sansoni V; Vitale J; Perego S; Gomarasca M; Verdelli C; Messina C; Sconfienza LM; Banfi G; Corbetta S; Lombardi G
    J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):690-701. PubMed ID: 38272849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Three Circulating MicroRNAs in Plasma as Clinical Biomarkers for Breast Cancer Detection.
    Wang S; Li L; Yang M; Wang X; Zhang H; Wu N; Jia K; Wang J; Li M; Wei L; Liu J
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
    Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
    Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic transcripts of LINC01311 and hsa-miR-146a-5p regulate neural development in a cellular model of Alzheimer's disease.
    Fan Y; Zhang J; Zhuang X; Geng F; Jiang G; Yang X
    IUBMB Life; 2021 Jul; 73(7):916-926. PubMed ID: 33830627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
    Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
    J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning.
    Yang F; Zhang J; Li B; Zhao Z; Liu Y; Zhao Z; Jing S; Wang G
    Int J Endocrinol; 2021; 2021():3984463. PubMed ID: 34335744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic potential of a circRNA-miRNA network in non-small cell lung cancer.
    Ma X; Lou C; Pan J; Zhou C; Zhao X; Li N; Tian H; Meng X
    J Mol Med (Berl); 2023 Jun; 101(6):671-684. PubMed ID: 37069371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.